Furthermore, the concentration of specific biomarkers in CSF, such as total tau (t-tau) and 14-3-3 protein, has been correlated with disease progression, providing valuable insights into the pathophysiological mechanisms underlying CJD [9]. The gene discussed is MAPT; the disease is Creutzfeldt Jacob disease.